Cargando…
Ferroptosis—A New Dawn in the Treatment of Organ Ischemia–Reperfusion Injury
Ischemia–reperfusion (I/R) is a common pathological phenomenon that occurs in numerous organs and diseases. It generally results from secondary damage caused by the recovery of blood flow and reoxygenation, followed by ischemia of organ tissues, which is often accompanied by severe cellular damage a...
Autores principales: | Zhou, Linxiang, Han, Shangting, Guo, Jiayu, Qiu, Tao, Zhou, Jiangqiao, Shen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688314/ https://www.ncbi.nlm.nih.gov/pubmed/36429080 http://dx.doi.org/10.3390/cells11223653 |
Ejemplares similares
-
Analysis of potential immune-related genes involved in the pathogenesis of ischemia-reperfusion injury following liver transplantation
por: Guo, Jiayu, et al.
Publicado: (2023) -
Ferroptosis: Opportunities and Challenges in Myocardial Ischemia-Reperfusion Injury
por: Zhao, Wei-kun, et al.
Publicado: (2021) -
Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal
por: Xia, Kang, et al.
Publicado: (2023) -
The pathological role of ferroptosis in ischemia/reperfusion-related injury
por: Yan, Hong-Fa, et al.
Publicado: (2020) -
Ferroptosis: A Novel Therapeutic Target for Ischemia-Reperfusion Injury
por: Chen, Yunqing, et al.
Publicado: (2021)